Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) shares were up 17.4% during trading on Tuesday . The company traded as high as GBX 23.11 ($0.29) and last traded at GBX 19.38 ($0.24). Approximately 188,557 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 365,568 shares. The stock had previously closed at GBX 16.50 ($0.21).
Celadon Pharmaceuticals Stock Down 7.7 %
The stock has a market capitalization of £13.02 million, a price-to-earnings ratio of -236.44 and a beta of -0.26. The business has a fifty day moving average of GBX 17.85 and a 200 day moving average of GBX 29.01. The company has a debt-to-equity ratio of 194.82, a current ratio of 1.92 and a quick ratio of 6.97.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Featured Articles
- Five stocks we like better than Celadon Pharmaceuticals
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- What is the Dogs of the Dow Strategy? Overview and Examples
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
- The 3 Best Fintech Stocks to Buy Now
- 3 Must-Have ETFs Set to Dominate This Quarter
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
